“OBJECTIVE:
Debilitating pain, occurring in 50-70% of multiple sclerosis (MS) patients, is poorly understood and infrequently studied. We summarized efficacy and safety data of cannabinoid-based drugs for neuropathic pain.
CONCLUSION:
Cannabinoids including the cannabidiol/THC buccal spray are effective in treating neuropathic pain in MS.”